Skip to content
Open access

Pericyte Snai1 ablation prevents pathological angiogenesis in retinopathy via extracellular matrix remodelling-mediated inhibition of endothelial cell activation

Oct 2026 · Experimental and Molecular Medicine · Vol 58, pp. 3609 - 3625 · 0 citations · 63 references
Medicine

Abstract

Pathological retinal neovascularization (RNV) is the leading cause of blindness. Pericytes are crucial for vascular stability and involved in RNV, but the underlying mechanism remains unclear. This study investigates the role and mechanism of Snai1, a transcription factor involved in endothelial–mesenchymal transition, in regulating pericytes during RNV. By analysing single-cell RNA-seq data from oxygen-induced retinopathy (OIR) mice, we identified a distinct subpopulation of ‘dysfunctional’ pericytes with enriched pro-angiogenic pathways and upregulated Snai1. Genetic deletion of Snai1 in pericytes markedly reduced pathological neovascular tufts and vascular leakage, while improving retinal function in OIR mice, without affecting physiological angiogenesis. Mechanistically, Snai1 in pericytes directly bound to promoters and upregulated key extracellular matrix (ECM) genes, including collagens and the crosslinking enzyme Lox, which remodelled the perivascular ECM into a pro-angiogenic niche. Indeed, Snai1-overexpressing pericytes enhanced endothelial cell proliferation and tube formation only upon direct cell–cell contacts in vitro, an effect abolished by knocking down Col4a1 or inhibiting Lox activity with β-aminopropionitrile (BAPN). A feedforward loop was identified where hypoxic ECs secreted ANGPT2 and TGFβ1, stabilizing Snai1 protein in pericytes. Importantly, intravitreal injection of BAPN in OIR mice phenocopied the Snai1 ablation in effectively inhibiting RNV and promoting vascular normalization. In summary, Snai1 in pericytes is a master regulator of pathological angiogenesis in RNV, programming pericytes to construct a pro-angiogenic ECM through collagen synthesis and crosslinking, facilitating aberrant vascular growth via contact-dependent pericyte/ECM–endothelial-cell interactions. Targeting the Snai1/ECM axis represents a potential ‘vascular normalization’ strategy for RNV-related diseases. Pathological retinal neovascularization (RNV) is a key feature of retinal vascular diseases such as diabetic retinopathy, leading to fragile and haemorrhage-prone vessels. Current anti-VEGF therapies often fall short owing to poor response and recurrence. This study explores the role of pericytes and the extracellular matrix (ECM) in RNV, focusing on the transcription factor Snai1. Researchers used human samples and animal models to show that Snai1 in pericytes is crucial for collagen secretion and crosslinking, which are vital for endothelial cell activation and pathological angiogenesis. Snai1 knockout in pericytes reduced neovascularization and improved retinal function by enhancing vessel integrity. The study highlights the potential of targeting the Snai1/ECM axis to treat RNV-related diseases, suggesting that future research could focus on ECM remodelling to restore vascular homeostasis and improve therapeutic outcomes. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.